Development and the need for implementation of a health-related quality of life measurement strategy for patients with soft tissue sarcoma undergoing preoperative radiotherapy
DOI:
https://doi.org/10.2340/1651-226X.2025.43110Keywords:
soft tissue sarcoma (STS), Health-related Quality of Life, preoperative radiotherapy, hypofractionated radiotherapy, sarcoma specific questionnaire, SCOPES trialAbstract
Background and purpose: Soft tissue sarcomas (STS) are a rare and heterogeneous group of tumours. Treatment strategies are based on histological subtype, patient performance status, tumour location, and size. Common treatment modalities include surgery, (neo)adjuvant chemotherapy, and (neo)adjuvant radiotherapy. While disease control and survival remain primary research focuses, health-related quality of life (HRQoL) is equally important. Accurately assessing HRQoL outcomes is particularly difficult due to the heterogeneity of STS, variations in treatment, tumour location and surgical interventions, and the prevalence of these rare cancers.
Patients and methods: To address this gap, a sarcoma-specific tool was developed complementing the most used cancer-generic EORTC QLQ-C30 questionnaire, with additional items tailored to the specific challenges of radiotherapy and surgery in sarcoma patients. The final questionnaire consists of the EQ-5D-5L, EORTC QLQ-C30, and additional EORTC Item Library items addressing stiffness, pain in muscles and bones, scar pain, as well as items of the PRO-CTCAE. The selection was made with significant input from patients with STS who underwent radiotherapy previously and with input from clinicians who were present at the multidisciplinary consultation.
Results and Interpretation: The newly developed HRQoL tool is currently undergoing validation within the SCOPES trial (NTC04425967), evaluating HRQoL outcomes in patients undergoing standard versus hypofractionated radiotherapy. This tool will lead to better understanding the full impact of treatment on sarcoma patients and hopefully, ultimately improve their HRQoL. Moreover, it provides a standardized framework that can be utilized across studies, facilitating the comparison of HRQoL data and enabling more consistent and comprehensive insights into patient outcomes.
Downloads
References
IKNL, NKR Cijfers – Incidentie per jaar, 2024 [Internet]. 2024 [cited 2024 Sep 10]. Available from: https://nkr-cijfers.iknl.nl/viewer/incidentie-per-jaar?language=nl_NL&viewerId=6cae7d3b-d48e-4250-9cf8-67b601dc7d36
Haas RL, Miah AB, LePechoux C, DeLaney TF, Baldini EH, Alektiar K, et al. Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies. Radiother Oncol. 2016;119(1);14–21.
https://doi.org/10.1016/j.radonc.2015.12.002 DOI: https://doi.org/10.1016/j.radonc.2015.12.002
Salerno KE, Alektiar KM, Baldini EH, Bedi M, Bishop AJ, Bradfield L, et al. Radiation therapy for treatment of soft tissue sarcoma in adults: executive summary of an ASTRO clinical practice guideline. Pract Radiat Oncol. 2021;11(5):339–51.
https://doi.org/10.1016/j.prro.2021.04.005 DOI: https://doi.org/10.1016/j.prro.2021.04.005
N.C.P.G.i. Oncology. NCCN clinical practice guidelines in oncology (NCCN Guidelines®) Soft Tissue Sarcoma Version 1.2024 [Internet]. 2024 [cited 2024 Apr 26]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf
Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, et al. Soft tissue and visceral sarcomas: ESMO-Euracan-Genturis clinical practice guidelines for diagnosis, treatment and follow-up(☆). Ann Oncol. 2021;32(11):1348–65.
https://doi.org/10.1016/j.annonc.2021.07.006 DOI: https://doi.org/10.1016/j.annonc.2021.07.006
Haas RL, Delaney TF, O’Sullivan B, Keus RB, Le Pechoux C, Olmi P, et al. Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where?, Int J Radiat Oncol Biol Phys. 2012;84(3):572–80.
https://doi.org/10.1016/j.ijrobp.2012.01.062 DOI: https://doi.org/10.1016/j.ijrobp.2012.01.062
Guadagnolo BA, Bassett RL, Mitra D, Farooqi A, Hempel C, Dorber C, et al. Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. Lancet Oncol. 2022;23(12):1547–57.
https://doi.org/10.1016/S1470-2045(22)00638-6 DOI: https://doi.org/10.1016/S1470-2045(22)00638-6
Gobo Silva ML, Lopes de Mello CA, Aguiar Junior S, D’Almeida Costa F, Stevanato Filho PR, Santoro Bezerra T, et al. Neoadjuvant hypofractionated radiotherapy and chemotherapy for extremity soft tissue sarcomas: safety, feasibility, and early oncologic outcomes of a phase 2 trial. Radiother Oncol. 2021;159;161–7.
https://doi.org/10.1016/j.radonc.2021.03.033 DOI: https://doi.org/10.1016/j.radonc.2021.03.033
Kalbasi A, Kamrava M, Chu FI, Telesca D, Van Dams R, Yang Y, et al. A phase II trial of 5-day neoadjuvant radiotherapy for patients with high-risk primary soft tissue sarcoma. Clin Cancer Res. 2020;26(8):1829–36.
https://doi.org/10.1158/1078-0432.CCR-19-3524 DOI: https://doi.org/10.1158/1078-0432.CCR-19-3524
Kılıç L, Ekenel M, Karabulut S, Ağaoğlu F, Darendeliler E. Neoadjuvant sequential chemoradiotherapy versus radiotherapy alone for treatment of high-risk extremity soft tissue sarcoma: a single-institution experience. Contemp Oncol (Pozn). 2017;21(1):60–5.
https://doi.org/10.5114/wo.2017.66658 DOI: https://doi.org/10.5114/wo.2017.66658
Koseła-Paterczyk H, Szacht M, Morysiński T, Ługowska I, Dziewirski W, Falkowski S, et al. Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas. Eur J Surg Oncol. 2014;40(12):1641–7.
https://doi.org/10.1016/j.ejso.2014.05.016 DOI: https://doi.org/10.1016/j.ejso.2014.05.016
Kubicek GJ, LaCouture T, Kaden M, Kim TW, Lerman N, Khrizman P, et al. Preoperative radiosurgery for soft tissue sarcoma. Am J Clin Oncol. 2018;41(1):86–9.
https://doi.org/10.1097/COC.0000000000000236 DOI: https://doi.org/10.1097/COC.0000000000000236
Leite ETT, Munhoz RR, Camargo VP, Lima L, Rebolledo DCS, Maistro CEB, et al. Neoadjuvant stereotactic ablative radiotherapy (SABR) for soft tissue sarcomas of the extremities, Radiother Oncol. 2021;161:222–9.
https://doi.org/10.1016/j.radonc.2021.06.027 DOI: https://doi.org/10.1016/j.radonc.2021.06.027
Parsai S, Lawrenz J, Kilpatrick S, Rubin B, Hymes C, Gray M, et al. Early outcomes of preoperative 5-fraction radiation therapy for soft tissue sarcoma followed by immediate surgical resection. Adv Radiat Oncol. 2020;5(6):1274–1279.
https://doi.org/10.1016/j.adro.2020.06.024 DOI: https://doi.org/10.1016/j.adro.2020.06.024
Den Hollander D, Van der Graaf WTA, Fiore M, Kasper B, Singer S, Desar IME, et al. Unravelling the heterogeneity of soft tissue and bone sarcoma patients’ health-related quality of life: a systematic literature review with focus on tumour location. ESMO Open. 2020;5(5):e000914.
https://doi.org/10.1136/esmoopen-2020-000914 DOI: https://doi.org/10.1136/esmoopen-2020-000914
Van Eck I, Den Hollander D, Desar IME, Soomers V,. Van de Sande MAJ, De Haan JJ, et al. Unraveling the heterogeneity of sarcoma survivors’ health-related quality of life regarding primary sarcoma location: results from the SURVSARC study. Cancers (Basel). 2020;12(11).
https://doi.org/10.3390/cancers12113083 DOI: https://doi.org/10.3390/cancers12113083
Blauwgeers H, Ho V, Kwast A, van der Zwan JM, de Peuter R, Schrieks M, et al. Kankerzorg in beeld – Zeldzame kanker. Utrecht: IKNL; 2018.
den Hollander D, Fiore M., Martin-Broto J, Kasper B, Casado Herraez A, Kulis D, et al. Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study Protocol. Cancers 2021;13(1):1–14.
https://doi.org/10.3390/cancers13010001 DOI: https://doi.org/10.3390/cancers13010001
European Organisation for Research and Treatment of Cancer (EORTC) item library [Internet]. 2024 [cited 2024 Sep 10]. Available from: https://itemlibrary.eortc.org/
European Organisation for Research and Treatment of Cancer (EORTC) WISP guideline [Internet]. [cited 2024 Nov 11]. Available from: https://qol.eortc.org/manual/eortc-wisp-guideline/
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Geraldien Florine Foppele, Lisette M. Wiltink, Marta Fiocco, Jules Lansu, Astrid N. Scholten, Winan J. van Houdt, Yvonne Schrage, Winette T.A. van der Graaf, Rick L.M. Haas, Olga Husson
This work is licensed under a Creative Commons Attribution 4.0 International License.
